MRNA Stock Analysis: Buy, Sell, or Hold?
MRNA - Moderna, Inc. Common Stock
$54.35
5.81 (11.97%)
▲
5d:
+19.79%
30d:
+5.99%
90d:
+32.53%
HOLD
MODERATE Confidence
Analysis Updated: May 8, 2026 12:00 AM ET
Earnings: May 01, 2026
0d
Smart Money Accumulation
MRNA is down 5.1% this week, but smart money is accumulating calls. Top strike: $40 2026-06-18 with 20,355 OI. Call ratio: 64% View Scanner →
Strength: 9.0/10
Get Alerted When MRNA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
31 traders called MRNA this week
84% bullish • 8 bearish
84% bullish • 8 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: MRNA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: MRNA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: MRNA is currently trading at $54.35, which is considered extended relative to its 30-day fair value range of $47.53 to $53.45.
Technical Outlook: Technically, MRNA is in a strong uptrend. Immediate support is located at $43.68, while resistance sits at $56.80. The stock is showing strong short-term momentum, up 12.0% recently.
Market Sentiment: MRNA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $43.37. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MRNA is in a strong uptrend. Immediate support is located at $43.68, while resistance sits at $56.80. The stock is showing strong short-term momentum, up 12.0% recently.
Market Sentiment: MRNA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $43.37. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$47.53 -
$53.45
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
Protect Your Profits
Holding MRNA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+12.0%)
- BEARISH: Trading 20.2% above Wall St target ($43.37)
Trading Range Analysis
30-Day Trading Range
$47.53 -
$53.45
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$43.68
Resistance Level
$56.80
Current Trend
Strong Uptrend
Technical data as of
May 8, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-11.43
Wall Street Target
$43.37
(-20.2%)
Revenue Growth (YoY)
260.2%
Earnings Growth (YoY)
-85.1%
Profit Margin
-143.6%
Share & Embed Analysis
Last updated: May 11, 2026 7:08 AM ET
Data refreshes hourly during market hours. Next update: 8:08 AM
Data refreshes hourly during market hours. Next update: 8:08 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MRNA showing a specific setup today?
Insider Activity (6 Months)
1
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Stephen Hoge
SELL
160009 shares
2026-02-23
Ro Khanna
BUY
2026-01-23
Noubar Afeyan
SELL
23853 shares
2025-12-11
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$449 | 52 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$23 | 55 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 65 BUY |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$208 | 46 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$297 | 60 HOLD |
Advanced MRNA Option Strategies
Professional options setups generated by AI based on today's MRNA price and gamma walls.
